Close Menu

Get Personal

With its purchase of SeqWright for an undisclosed sum, GE is investing more in personalized medicine, The Wall Street Journal's Health Blog says. SeqWright is a contract genomic research organization that offers sequencing services among others, and GE says the company will supplement its 2009 purchase of Clarient, a cancer diagnostics company, for $580 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.